11 May 2021
Latham & Watkins Advises Ginkgo Bioworks in US$15 Billion de-SPAC Merger with Soaring Eagle Acquisition Corp.
Advising firms
Deal team
39 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Paul Sheridan Lead | Latham & Watkins LLP | Partner | mergers and acquisitions | Washington, D.C. |
| Rachel Sheridan Lead | Latham & Watkins LLP | Partner | capital markets | Washington, D.C. |
| Shagufa Hossain Lead | Latham & Watkins LLP | Partner | capital markets | Washington, D.C. |
| Kristen Grannis | Latham & Watkins LLP | Partner | mergers and acquisitions | Boston/New York |
| Kristin Rulison | Latham & Watkins LLP | Associate | mergers and acquisitions | New York |
| Monica Hernandez | Latham & Watkins LLP | Associate | mergers and acquisitions | Washington, D.C. |
| Christopher Lloyd | Latham & Watkins LLP | Associate | mergers and acquisitions | Boston |
| Jessica Lennon | Latham & Watkins LLP | Associate | capital markets | Washington, D.C. |
| Gary DePalo | Latham & Watkins LLP | Associate | capital markets | Washington, D.C. |
| Brooke Padgett | Latham & Watkins LLP | Associate | capital markets | Washington, D.C. |
| Emily Taylor | Latham & Watkins LLP | Partner | general corporate and governance | Boston |
| John Chory | Latham & Watkins LLP | Partner | general corporate and governance | Boston |
| Belinda King | Latham & Watkins LLP | Associate | general corporate and governance | Boston |
| Tyler Mills | Latham & Watkins LLP | Associate | general corporate and governance | Boston |
| Rene de Vera | Latham & Watkins LLP | Not stated | tax | Not stated |
| Eni Kassim | Latham & Watkins LLP | Associate | tax | Washington, D.C. |
| David Della Rocca | Latham & Watkins LLP | Partner | benefits and compensation | Washington, D.C. |
| Marysia Mullen | Latham & Watkins LLP | Associate | benefits and compensation | Washington, D.C. |
| Courtney Thomson | Latham & Watkins LLP | Associate | benefits and compensation | Washington, D.C. |
| Laura Ferrell | Latham & Watkins LLP | Partner | regulatory | Chicago |
| David Tolley | Latham & Watkins LLP | Partner | regulatory | Boston |
| Nicholas Lessin | Latham & Watkins LLP | Associate | regulatory | Boston |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Counsel | FDA | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Associate | FDA | Washington, D.C. |
| Alan Tamarelli | Latham & Watkins LLP | Partner | intellectual property | New York |
| Sarah Gagan | Latham & Watkins LLP | Partner | intellectual property | Boston |
| Deborah Hinck | Latham & Watkins LLP | Associate | intellectual property | Boston |
| Seth Appiah-Opoku | Latham & Watkins LLP | Associate | intellectual property | Boston |
| Heather Deixler | Latham & Watkins LLP | Counsel | data privacy | Bay Area |
| James Barrett | Latham & Watkins LLP | Partner | environmental | Washington, D.C. |
| Sam Scott | Latham & Watkins LLP | Associate | environmental | Washington, D.C. |
| Shira Bressler | Latham & Watkins LLP | Counsel | real estate | New York |
| Erin Brown Jones | Latham & Watkins LLP | Partner | compliance | Washington, D.C. |
| Les Carnegie | Latham & Watkins LLP | Not stated | compliance | Not stated |
| Faiza Hasan | Latham & Watkins LLP | Associate | compliance | Washington, D.C. |
| Elizabeth Annis | Latham & Watkins LLP | Not stated | compliance | Not stated |
| Peter Todaro | Latham & Watkins LLP | Counsel | antitrust | Washington, D.C. |
| Joseph Simei | Latham & Watkins LLP | Counsel | antitrust | Washington, D.C. |
Stated terms
- Stated value
- USD 15bn (US$15 Billion)
- What the figure measures
- Enterprise value
- Client
- Ginkgo Bioworks, Inc.Buy-side
- Counterparties
- Soaring Eagle Acquisition Corp. (Sell-side)